This Article Free Full Text (Free PDF) Free References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (2) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Kostapanos, M. S. Articles by Elisaf, M. S. Search for Related Content PubMed PubMed Citation Articles by Kostapanos, M. S. Articles by Elisaf, M. S. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Statins Social Bookmarking                         What's this?

Dose-Dependent Effect of Rosuvastatin Treatment on Urinary Protein Excretion

Department of Internal Medicine, School of Medicine, University of Ioannina, Greece

Haralampos J. Milionis, MD

Department of Internal Medicine, School of Medicine, University of Ioannina, Greece

Vasilios G. Saougos, MD

Department of Internal Medicine, School of Medicine, University of Ioannina, Greece

Konstantinos G. Lagos, MD

Department of Internal Medicine, School of Medicine, University of Ioannina, Greece

Christine Kostara, PhD

Laboratory of Clinical Chemistry, School of Medicine, University of Ioannina, Greece

Eleni T. Bairaktari, PhD

Laboratory of Clinical Chemistry, School of Medicine, University of Ioannina, Greece

Moses S. Elisaf, MD

Department of Internal Medicine, School of Medicine, University of Ioannina, Greece, egepi{at}cc.uoi.gr

Concerns have been raised because of observations of proteinuria associated with rosuvastatin treatment. In this open-label study, a potential dose-dependent effect was investigated of rosuvastatin on urinary protein excretion and renal function parameters in 90 hyperlipidemic patients randomly assigned to rosuvastatin 10 mg/day (n = 45) or 20 mg/day (n = 45). Urinary samples were collected from patients and 40 age- and gender-matched controls to determine electrolyte, uric acid, creatinine, and protein (total, albumin, IgG, and 1-microglobulin) levels at baseline and after 12 weeks. A dose-dependent increase in the excretion of 1-microglobulin (17.6% in rosuvastatin 10 vs 34.9% in rosuvastatin, 20 mg/day; P = .03 for the comparison between groups) was observed. A trend toward an increase in the estimated glomerular filtration rate was noted in only patients receiving 20 mg/day of rosuvastatin. These findings indicate that rosuvastatin treatment increases the urinary excretion of 1-microglobulin urinary excretion in a dose-dependent manner without adversely affecting renal function.

Key Words: 1-microglobulin • dose-dependent effect • proteinuria • renal function • rosuvastatin

Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 12, No. 4, 292-297 (2007)
DOI: 10.1177/1074248407306676


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. S. Kostapanos, H. J. Milionis, T. D. Filippatos, L. G. Christogiannis, E. T. Bairaktari, A. D. Tselepis, and M. S. Elisaf Dose-dependent Effect of Rosuvastatin Treatment on HDL-subfraction Phenotype in Patients With Primary Hyperlipidemia Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2009; 14(1): 5 - 13. [Abstract] [PDF]

				M. S. Kostapanos, H. J. Milionis, and M. S. Elisaf An Overview of the Extra-Lipid Effects of Rosuvastatin Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2008; 13(3): 157 - 174. [Abstract] [PDF]